Juncheng Wang

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression.

Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression.

Journal: iScience

Published: August 27, 2025

Erythropoiesis-inosine metabolic axis failure underlying retinal neurodegeneration in glaucoma: novel diagnoses and therapies.

Erythropoiesis-inosine metabolic axis failure underlying retinal neurodegeneration in glaucoma: novel diagnoses and therapies.

Journal: Experimental & molecular medicine

Published: July 29, 2025

Targeting PERP promotes anti-tumor immunity in HNSCC by regulating tumor immune microenvironment and metabolic homeostasis.

Targeting PERP promotes anti-tumor immunity in HNSCC by regulating tumor immune microenvironment and metabolic homeostasis.

Journal: Molecular cancer

Published: February 24, 2025

Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC.

Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC.

Journal: Scientific reports

Published: September 29, 2024

ZNF683+ NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment.

ZNF683+ NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment.

Journal: Nature communications

Published: August 29, 2024

Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma.

Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma.

Journal: Cancer gene therapy

Published: June 02, 2021

MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment.

MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment.

Journal: iScience

Published: May 21, 2021

Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.

Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.

Journal: International immunopharmacology

Published: March 07, 2021

Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma.

Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma.

Journal: Aging

Published: February 11, 2021

Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma.

Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma.

Journal: PeerJ

Published: July 27, 2020

Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.

Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.

Journal: Scientific reports

Published: June 02, 2020

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning.

Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning.

Journal: Frontiers in genetics

Published: May 27, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026